Evidence map›Paper›PMID 32984549›Full record

ArticleWellcome open research2020

Sub-Saharan Africa preparedness and response to the COVID-19 pandemic: A perspective of early career African scientists.

Gisele Umviligihozo, Lucy Mupfumi, Nelson Sonela, Delon Naicker, Ekwaro A Obuku, Catherine Koofhethile, Tuelo Mogashoa, Anne Kapaata, Geoffrey Ombati, Clive M Michelo and 3 more

Open access · goldAbstract read
In one paragraph

Article in Wellcome open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 10 countries.

Gisele UmviligihozoFaculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, V5A 1S6, Canada.ORCID https://orcid.org/0000-0001-9841-1040
Lucy MupfumiBotswana Harvard AIDS Institute Partnership (BHP), Private Bag BO 320, Bontleng, Gaborone, Botswana.ORCID https://orcid.org/0000-0002-2290-2481
Nelson SonelaChantal Biya International Reference Center for research on the management and prevention of HIV/AIDS (CIRCB), Yaoundé, B.P.: 3077, Cameroon.ORCID https://orcid.org/0000-0001-7137-1130
Delon NaickerHIV Pathogenesis Programme, The Doris Duke Medical Research Institute, Nelson R. Mandela, School of Medicine, University of KwaZulu-Natal, Durban, 4001, South Africa.
Ekwaro A ObukuCoVID Pandemic Rapid Evidence Synthesis Group (CoVPRES), Africa Centre for Systematic Reviews and Knowledge Translation, College of Health Sciences, Makerere University, Kampala, P.O. Box 7072, Uganda.ORCID https://orcid.org/0000-0001-5311-2346
Catherine KoofhethileHarvard T.H. Chan School of Public Health, Boston, 651 Huntington Ave, Boston, MA, 02115, USA.ORCID https://orcid.org/0000-0001-5475-413X
Tuelo MogashoaBotswana Harvard AIDS Institute Partnership (BHP), Private Bag BO 320, Bontleng, Gaborone, Botswana.ORCID https://orcid.org/0000-0003-4156-8746
Anne KapaataInternational AIDS Vaccine Initiative (IAVI)- Vaccine, Immunology, Science and Technology for Africa (VISTA), Medical Research Council (MRC)/ (Uganda Virus Research Institute) UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, P.O.Box 49, Uganda.
Geoffrey OmbatiKenya AIDS Vaccine Initiative-Institute of Clinical Research (KAVI-ICR), College of Health Sciences, University of Nairobi, Nairobi, P.O. Box 19676, Kenya.
Clive M MicheloRwanda Zambia HIV Research Group (RZHRG), Kigali Rwanda, Lusaka and Ndola, PostNet 412, P/Bag E891, Zambia.
Kimani MakobuKenya Medical Research Institute (KEMRI), Wellcome Trust Research Program (KWTRP), Kilifi, P.O Box 230, Kenya.ORCID https://orcid.org/0000-0001-9275-4018
Olamide TodowedeCenter for Health Services Studies, University of Kent, Canterbury, CT2 7NF, UK.ORCID https://orcid.org/0000-0002-5785-1426
Sheila N BalindaInternational AIDS Vaccine Initiative (IAVI)- Vaccine, Immunology, Science and Technology for Africa (VISTA), Medical Research Council (MRC)/ (Uganda Virus Research Institute) UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, P.O.Box 49, Uganda.
Botswana Harvard AIDS Institute Partnership · BWUganda Virus Research Institute · UGHarvard University · USKenya Medical Research Institute · KEMakerere University · UGRwanda Zambia HIV Research Group · RWSimon Fraser University · CAUniversity of Kent · GBUniversity of KwaZulu-Natal · ZAUniversity of Nairobi · KEUniversity of Rome Tor Vergata · IT

Funding

Wellcome Trust
6 · The paper itself

Abstract

Emerging highly transmissible viral infections such as SARS-CoV-2 pose a significant global threat to human health and the economy. Since its first appearance in December 2019 in the city of Wuhan, Hubei province, China, SARS-CoV-2 infection has quickly spread across the globe, with the first case reported on the African continent, in Egypt on February 14

Indexed as

and response.COVID-19pandemicpreparednessSARS-CoV-2Sub-Saharan Africa

Identifiers

PMID32984549
PMCPMC7499400
OpenAlexW3041209413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.